Despite soaring global demand for healthcare, the challenge of profitably developing treatments has never been greater or more ethically complex. Can pharma giants strike the right balance?
Recent insights
1 December 2020
Deciphering the complex world of underpayment of wages: compliance and enforcement
13 November 2020
IP in a time of crisis – What does pharma have to do with a low-carbon future?
2 November 2020
The Healthcare Law Review - 4th Edition: Russia Chapter
23 September 2020
The Italian medicines agency AIFA opens a public consultation on the draft guidelines for the preparation of the dossier supporting a price and reimbursement application
31 August 2020
Digihealth and the dash for data – The key legal issues
21 August 2020
Costs of deception – Big fine from Australian watchdog shows need for credible privacy statements
21 July 2020
Can predictive analytics prevent employee misconduct?
21 July 2020
Big data and Modern Slavery – Progress not panacea
21 July 2020
Using big data to fight financial crime
21 July 2020
Digital forensics in investigations and the growing data burden
21 July 2020
Regulators lead businesses in monitoring of misconduct
15 July 2020
Where is the balance now? Preliminary injunctions in pharmaceutical patent proceedings in 2020 and beyond
